Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.


Smoldering Multiple Myeloma


Male or Female


18+ years

View more eligibility criteria on ClinicalTrials.gov
Study Locations

A.O. Papa Giovanni XXIII

Bergamo, Italy

A.O. di Padova

Padova, Italy

A.O.U. Careggi

Firenze, Italy

A.O.U. Maggiore della Carità Novara

Novara, Italy

A.O.U. Policlinico S. Martino - Ematologia

Genova, Italy

A.O.U. di Parma - U.O Ematologia e CTMO

Parma, Italy

AOU Consorziale Policlinico di Bari

Bari, Italy

Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens

Athens, Greece

CHD Vendée

La Roche-sur-Yon, France

CHRU Hôpital Bretonneau

Tours, France

CHRU de Lille - Hopital Claude Huriez

Lille, France

CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 NANTES Cedex 1, FRANCE

Nantes, France

CHU NICE - Hôpital Archet

Nice, France

CHU Poitiers - Pôle régional de Cancérologie

Poitiers, France

CHU Saint Eloi Département d'Hématologie Clinique

Montpellier, France

Clinica Ematologica Azienda Sanitaria Universitaria Friuli Centrale

Udine, Italy

Erasmus MC

Rotterdam, Netherlands

Fondazione IRCCS Policlinico S. Matteo

Pavia, Italy

Helsinki University Hospital

Helsinki, Finland

Maastricht UMC

Maastricht, Netherlands

Meldola-Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.)

Meldola, Italy

Oslo Myeloma Center

Oslo, Norway, 0450

Ospedale Papardo

Messina, Italy

Ospedale Santo Spirito

Roma, Italy

St. Antonius Ziekenhuis

Nieuwegein, Netherlands